StockDuty ← Dashboard Aug 29, 2026 09:02 PM ET
CatalystFDA/Bio

Sanofi (ENXTPA:SAN) Permanently Halted Its Phase 3 Infant RSV Vaccine Trial

Phase 3 trial permanently halted signals major clinical setback for Sanofi’s RSV vaccine.

What changed
Why it matters
Phase 3 trial permanently halted signals major clinical setback for Sanofi’s RSV vaccine.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →